cerense (SM)
home  |  genzyme  |  pharmidex  |  contact
The Blood-Brain Barrier is Open For Business.

Come see us next at:

Drug Discovery for Neurodegeneration Conference
Washington D.C.
February 2-3, 2009

Cerense

CerenseSM is the world's first integrated solution to release the value of your CNS portfolio by unlocking the blood-brain barrier and measuring brain penetration. This is achieved through the combination of Genzyme Pharmaceuticals' patented CNS drug delivery technology and the unique expertise of Pharmidex to determine neuro-pharmacokinetics.